Abbott Laboratories' profit fell 2.6 percent as sales missed estimates, hurt by the rising dollar and growing generic competition to the anti-seizure medicine Depakote. The company's shares declined. Report [1]
Links:
[1] http://www.bloomberg.com/apps/news?pid=20601202&sid=aWTXKa.Q1Su8